Devesh U. Kapoor – författare

Nanodots for Cancer Diagnosis and Treatment presents a pioneering exploration of nano-scale drug delivery systems that promise to revolutionize cancer care. This book, with insights from global scientific collaborations, delves into various nanodots employed in cancer diagnosis and treatment. The book provides a comprehensive overview of nanotechnology's role in cancer care, including the synthesis and characterization of nanodots and their importance in cancer imaging. It also covers various treatment options and offers practical suggestions for improving nanodots for cancer imaging and therapy, making it an invaluable resource for drug formulation experts, drug delivery specialists, oncologists, and translators.Nanodots enhance precision and effectiveness in delivering therapeutic agents to target sites within the body, representing a significant advancement in medical science.Provides a deep understanding of cancer pathophysiology to stay updated with current trends and challenges in cancer diagnosis and treatmentOffers groundbreaking insights into the potential of nanodots to revolutionize both diagnosis and treatment methodologiesNavigates through the complexities of biocompatibility and toxicological concerns related to nanodots, providing a thorough examination of safety issues

Nanodots for Cancer Diagnosis and Treatment presents a pioneering exploration of nano-scale drug delivery systems that promise to revolutionize cancer care. This book, with insights from global scientific collaborations, delves into various nanodots employed in cancer diagnosis and treatment. The book provides a comprehensive overview of nanotechnology's role in cancer care, including the synthesis and characterization of nanodots and their importance in cancer imaging. It also covers various treatment options and offers practical suggestions for improving nanodots for cancer imaging and therapy, making it an invaluable resource for drug formulation experts, drug delivery specialists, oncologists, and translators.Nanodots enhance precision and effectiveness in delivering therapeutic agents to target sites within the body, representing a significant advancement in medical science. - Provides a deep understanding of cancer pathophysiology to stay updated with current trends and challenges in cancer diagnosis and treatment- Offers groundbreaking insights into the potential of nanodots to revolutionize both diagnosis and treatment methodologies- Navigates through the complexities of biocompatibility and toxicological concerns related to nanodots, providing a thorough examination of safety issues

Eye Melanoma Unveiled: Cutting-Edge Diagnosis, Revolutionary Treatments and Advanced Drug Delivery delves into the latest advancements in drug delivery systems for diagnosing and treating eye melanoma. Compiled by leading scientists globally, the book thoroughly examines innovative drug delivery techniques utilized in uveal melanoma treatments, beginning with an overview of the disease's epidemiology, risk factors, pathogenesis, and molecular mechanisms. The book further discusses imaging techniques and diagnostic methods essential for precise disease identification.Despite stable incidence rates over the past thirty years and enhanced local treatments, survival rates for uveal melanoma have not notably improved. Recent genetic and cytogenetic developments have improved prognostication and cancer identification with high metastatic potential. This book is invaluable for specialists in drug formulation and delivery, eye oncologists, translational researchers, and life scientists.Includes an overview of current trends and challenges in eye melanoma treatmentDelves into the potential of novel drug delivery systems in the effective management of uveal melanomaCovers a range of treatment options for conjunctival melanoma, including cryotherapy, brachytherapy, topical chemotherapy, and immunotherapySupplemented with practical examples that illustrate key points and applications, bridging the gap between theoretical knowledge and rigorous investigation

Eye Melanoma Unveiled: Cutting-Edge Diagnosis, Revolutionary Treatments and Advanced Drug Delivery delves into the latest advancements in drug delivery systems for diagnosing and treating eye melanoma. Compiled by leading scientists globally, the book thoroughly examines innovative drug delivery techniques utilized in uveal melanoma treatments, beginning with an overview of the disease's epidemiology, risk factors, pathogenesis, and molecular mechanisms. The book further discusses imaging techniques and diagnostic methods essential for precise disease identification.Despite stable incidence rates over the past thirty years and enhanced local treatments, survival rates for uveal melanoma have not notably improved. Recent genetic and cytogenetic developments have improved prognostication and cancer identification with high metastatic potential. This book is invaluable for specialists in drug formulation and delivery, eye oncologists, translational researchers, and life scientists. - Includes an overview of current trends and challenges in eye melanoma treatment- Delves into the potential of novel drug delivery systems in the effective management of uveal melanoma- Covers a range of treatment options for conjunctival melanoma, including cryotherapy, brachytherapy, topical chemotherapy, and immunotherapy- Supplemented with practical examples that illustrate key points and applications, bridging the gap between theoretical knowledge and rigorous investigation

Nanocarriers in Prostate Cancer: Advanced Diagnosis and Treatment Strategies provides a comprehensive, up-to-date resource on the latest advancements in nanotechnology for prostate cancer therapy. Sections delve into different types of nanomaterials, including polymeric nanoparticles, DNA origami nanocarriers, and dendrimers. Each chapter explores their unique applications in targeted drug delivery, imaging, and therapeutic strategies, providing detailed insights into how nanotechnology revolutionizes prostate cancer care. This book benefits researchers, clinicians, and students focused on oncology and nanomedicine by offering a deep dive into the potential of nanocarriers in prostate cancer treatment.This book bridges the gap between cutting-edge research and clinical applications, offering insights into how various nanocarriers enhance drug delivery, improve imaging techniques, and provide targeted, less invasive treatments. It serves as a valuable resource for developing more effective, personalized treatments, leading to improved patient outcomes and reduced toxicity associated with traditional therapies.Provides in-depth coverage of nanocarrier types, showcasing their specific roles in prostate cancer treatmentIntegrates the latest research findings with practical clinical applicationsOffers valuable insights and practical examples that help advance understanding and application of nanotechnology in prostate cancer therapy

Nanocarriers in Prostate Cancer: Advanced Diagnosis and Treatment Strategies provides a comprehensive, up-to-date resource on the latest advancements in nanotechnology for prostate cancer therapy. Sections delve into different types of nanomaterials, including polymeric nanoparticles, DNA origami nanocarriers, and dendrimers. Each chapter explores their unique applications in targeted drug delivery, imaging, and therapeutic strategies, providing detailed insights into how nanotechnology revolutionizes prostate cancer care. This book benefits researchers, clinicians, and students focused on oncology and nanomedicine by offering a deep dive into the potential of nanocarriers in prostate cancer treatment.This book bridges the gap between cutting-edge research and clinical applications, offering insights into how various nanocarriers enhance drug delivery, improve imaging techniques, and provide targeted, less invasive treatments. It serves as a valuable resource for developing more effective, personalized treatments, leading to improved patient outcomes and reduced toxicity associated with traditional therapies. - Provides in-depth coverage of nanocarrier types, showcasing their specific roles in prostate cancer treatment- Integrates the latest research findings with practical clinical applications- Offers valuable insights and practical examples that help advance understanding and application of nanotechnology in prostate cancer therapy

Bladder Cancer Breakthroughs: A Global Perspective on Diagnosis, Treatment, and Patient Care is a groundbreaking scientific resource that delves into the latest advancements in the diagnosis and treatment of bladder cancer, a prevalent malignancy affecting hundreds of thousands worldwide. This meticulously curated volume brings together contributions from leading scientists and healthcare professionals from around the globe, providing a comprehensive overview of contemporary understanding and innovative strategies in managing this complex disease. Bladder Cancer Breakthroughs: A Global Perspective on Diagnosis, Treatment, and Patient Care is not merely a collection of research findings; it is a vital resource that fosters a holistic perspective on patient-centered care. By synthesizing clinical expertise and evidence-based practices, this book aims to empower healthcare providers with the knowledge and tools needed to improve outcomes for individuals living with bladder cancer, ultimately contributing to the global fight against this challenging disease. This book serves as an essential guide for healthcare providers, including physicians, oncologists, immunologists, pharmacists, and physical therapists, striving to enhance patient care and treatment outcomesProvides an in-depth exploration of bladder cancer, including its epidemiology, risk factors, and cutting-edge diagnostic techniquesAddresses the latest therapeutic interventions, from traditional surgical methods to innovative approaches using nanotechnology and artificial intelligence, ensuring a holistic understanding of the diseaseFeatures contributions from leading scientists and healthcare professionals from around the world, emphasizing a global perspective on bladder cancer managementDesigned to educate healthcare providers through clear, evidence-based insights supported by extensive tables, figures, and illustrations. These visual aids enhance comprehension and retention, making complex concepts more accessible and applicable in clinical settings.

Bladder Cancer Breakthroughs: A Global Perspective on Diagnosis, Treatment, and Patient Care is a groundbreaking scientific resource that delves into the latest advancements in the diagnosis and treatment of bladder cancer, a prevalent malignancy affecting hundreds of thousands worldwide. This meticulously curated volume brings together contributions from leading scientists and healthcare professionals from around the globe, providing a comprehensive overview of contemporary understanding and innovative strategies in managing this complex disease. Bladder Cancer Breakthroughs: A Global Perspective on Diagnosis, Treatment, and Patient Care is not merely a collection of research findings; it is a vital resource that fosters a holistic perspective on patient-centered care. By synthesizing clinical expertise and evidence-based practices, this book aims to empower healthcare providers with the knowledge and tools needed to improve outcomes for individuals living with bladder cancer, ultimately contributing to the global fight against this challenging disease. This book serves as an essential guide for healthcare providers, including physicians, oncologists, immunologists, pharmacists, and physical therapists, striving to enhance patient care and treatment outcomes- Provides an in-depth exploration of bladder cancer, including its epidemiology, risk factors, and cutting-edge diagnostic techniques- Addresses the latest therapeutic interventions, from traditional surgical methods to innovative approaches using nanotechnology and artificial intelligence, ensuring a holistic understanding of the disease- Features contributions from leading scientists and healthcare professionals from around the world, emphasizing a global perspective on bladder cancer management- Designed to educate healthcare providers through clear, evidence-based insights supported by extensive tables, figures, and illustrations. These visual aids enhance comprehension and retention, making complex concepts more accessible and applicable in clinical settings.

Myasthenia Gravis: Disease, Diagnosis and Management is a comprehensive resource that explores recent advancements in diagnosing and treating Myasthenia Gravis, a rare autoimmune disease affecting the neuromuscular junction. With contributions from global experts, this book addresses the increasing prevalence of Myasthenia Gravis, reflecting the latest in diagnostic techniques and novel therapies such as complement inhibitors and FcRn antagonists. It aims to support healthcare professionals in delivering optimal care through evidence-based insights and patient-centered approaches. The book is divided into several chapters, beginning with an overview of the pathogenesis and immunoregulatory defects in Myasthenia Gravis. Subsequent chapters cover diagnostic methods, non-immunosuppressive treatments, and biological therapies targeting the immune system. Key topics include the role of intravenous immunoglobulin (IVIg) and plasma exchange (PLEX) in severe exacerbations, thymectomy, molecular mechanisms, and the potential of hematopoietic stem cell transplants. The book also delves into precision medicine, AI applications, clinical trial considerations, and novel therapeutics like anti-FcRn antibodies. Management strategies for ocular Myasthenia Gravis, and a holistic view of living with the disease are also discussed. Myasthenia Gravis: Disease, Diagnosis and Management is invaluable for healthcare providers, physicians, immunologists, ophthalmologists, rheumatologists, physical therapists, pharmacists, and translators. It offers a modern guide to understanding and managing Myasthenia Gravis, integrating clinical expertise with the latest research to improve patient outcomes.Explores pathogenesis, diagnosis, and treatment options for Myasthenia Gravis, providing a complete understanding of the diseaseHighlights cutting-edge therapies like complement inhibitors and FcRn antagonists for improved patient outcomesEnsures authoritative and up-to-date information contributed by global expertsOffers evidence-based strategies for healthcare professionals to optimize Myasthenia Gravis managementIntegrates clinical expertise with patient-centered care for a well-rounded perspective on disease management

Myasthenia Gravis: Disease, Diagnosis and Management is a comprehensive resource that explores recent advancements in diagnosing and treating Myasthenia Gravis, a rare autoimmune disease affecting the neuromuscular junction. With contributions from global experts, this book addresses the increasing prevalence of Myasthenia Gravis, reflecting the latest in diagnostic techniques and novel therapies such as complement inhibitors and FcRn antagonists. It aims to support healthcare professionals in delivering optimal care through evidence-based insights and patient-centered approaches. The book is divided into several chapters, beginning with an overview of the pathogenesis and immunoregulatory defects in Myasthenia Gravis. Subsequent chapters cover diagnostic methods, non-immunosuppressive treatments, and biological therapies targeting the immune system. Key topics include the role of intravenous immunoglobulin (IVIg) and plasma exchange (PLEX) in severe exacerbations, thymectomy, molecular mechanisms, and the potential of hematopoietic stem cell transplants. The book also delves into precision medicine, AI applications, clinical trial considerations, and novel therapeutics like anti-FcRn antibodies. Management strategies for ocular Myasthenia Gravis, and a holistic view of living with the disease are also discussed. Myasthenia Gravis: Disease, Diagnosis and Management is invaluable for healthcare providers, physicians, immunologists, ophthalmologists, rheumatologists, physical therapists, pharmacists, and translators. It offers a modern guide to understanding and managing Myasthenia Gravis, integrating clinical expertise with the latest research to improve patient outcomes. - Explores pathogenesis, diagnosis, and treatment options for Myasthenia Gravis, providing a complete understanding of the disease- Highlights cutting-edge therapies like complement inhibitors and FcRn antagonists for improved patient outcomes- Ensures authoritative and up-to-date information contributed by global experts- Offers evidence-based strategies for healthcare professionals to optimize Myasthenia Gravis management- Integrates clinical expertise with patient-centered care for a well-rounded perspective on disease management

Revolutionizing Cancer Treatment: The Power of Molecularly Imprinted Polymers for Precision Therapy examines the transformative role of molecularly imprinted polymers (MIPs) in cancer management and treatment. This comprehensive book explores how MIPs can be utilized to create advanced drug delivery systems specifically targeting various cancer types, including breast, prostate, and lung cancers, among others. By integrating molecular imprinting techniques with precision oncology, this resource provides valuable insights for researchers, clinicians, and pharmaceutical developers aiming to enhance cancer therapies. Structured in a user-friendly format, the book includes detailed chapters dedicated to specific cancer types, highlighting the design and application of MIPs in targeted therapies. Users will find flow charts, process diagrams, and case studies to facilitate understanding of complex concepts. The necessity for this book arises from the pressing demand for precision medicine in oncology, as conventional treatments often suffer from issues of specificity and efficacy. Ultimately, this work serves as a vital reference for students, researchers, and healthcare professionals dedicated to advancing cancer treatment through innovative drug delivery systems. - Focuses on a distinct cancer type (e.g., breast, prostate, pancreatic, and lung), detailing how MIPs can be tailored for drug delivery and treatment- Provides a solid foundation in the principles and latest advancements of this technology, addressing challenges and opportunities for researchers and industrial professionals seeking to innovate or enhance current therapeutic techniques- Emphasizes how MIPs can serve as precision tools in cancer therapy- Delves into various molecular imprinting methods used to develop MIP-based drug delivery systems

Revolutionizing Cancer Treatment: The Power of Molecularly Imprinted Polymers for Precision Therapy examines the transformative role of molecularly imprinted polymers (MIPs) in cancer management and treatment. This comprehensive book explores how MIPs can be utilized to create advanced drug delivery systems specifically targeting various cancer types, including breast, prostate, and lung cancers, among others. By integrating molecular imprinting techniques with precision oncology, this resource provides valuable insights for researchers, clinicians, and pharmaceutical developers aiming to enhance cancer therapies. Structured in a user-friendly format, the book includes detailed chapters dedicated to specific cancer types, highlighting the design and application of MIPs in targeted therapies. Users will find flow charts, process diagrams, and case studies to facilitate understanding of complex concepts. The necessity for this book arises from the pressing demand for precision medicine in oncology, as conventional treatments often suffer from issues of specificity and efficacy. Ultimately, this work serves as a vital reference for students, researchers, and healthcare professionals dedicated to advancing cancer treatment through innovative drug delivery systems.Focuses on a distinct cancer type (e.g., breast, prostate, pancreatic, and lung), detailing how MIPs can be tailored for drug delivery and treatmentProvides a solid foundation in the principles and latest advancements of this technology, addressing challenges and opportunities for researchers and industrial professionals seeking to innovate or enhance current therapeutic techniquesEmphasizes how MIPs can serve as precision tools in cancer therapyDelves into various molecular imprinting methods used to develop MIP-based drug delivery systems

Cutting-edge Nanocarrier-Based Strategies in the Management of Leukaemia addresses the importance of nanocarriers in leukemia treatment. The book explores advancements in nanotechnology, highlighting therapies like siRNA, miRNA, and gene therapy that improve patient outcomes. Sections provide an introduction to leukemia, covering its epidemiology and risk factors, discuss innovative therapies and the use of various nanocarriers, such as polymeric nanoparticles, liposomes, dendrimers, and hydrogels, and discuss precision medicine, AI in leukemia care, and strategies to overcome treatment resistance. The book is enriched with tables, figures, and images, giving healthcare providers, including physicians, immunologists, oncologists, and pharmacists an invaluable resource on cutting-edge therapies.Provides an in-depth exploration of various nanocarrier-based therapies for leukemiaIntegrates perspectives from multiple fields, such as nanotechnology, artificial intelligence, and personalized medicineEnhances comprehension and provides practical insights, helping readers better understand and apply the discussed therapies in clinical settings

Cutting-edge Nanocarrier-Based Strategies in the Management of Leukaemia addresses the importance of nanocarriers in leukemia treatment. The book explores advancements in nanotechnology, highlighting therapies like siRNA, miRNA, and gene therapy that improve patient outcomes. Sections provide an introduction to leukemia, covering its epidemiology and risk factors, discuss innovative therapies and the use of various nanocarriers, such as polymeric nanoparticles, liposomes, dendrimers, and hydrogels, and discuss precision medicine, AI in leukemia care, and strategies to overcome treatment resistance. The book is enriched with tables, figures, and images, giving healthcare providers, including physicians, immunologists, oncologists, and pharmacists an invaluable resource on cutting-edge therapies. - Provides an in-depth exploration of various nanocarrier-based therapies for leukemia- Integrates perspectives from multiple fields, such as nanotechnology, artificial intelligence, and personalized medicine- Enhances comprehension and provides practical insights, helping readers better understand and apply the discussed therapies in clinical settings

Role of Nanocarriers in Management of Non-Hodgkin Lymphoma is a pivotal resource that explores the transformative impact of nanotechnology on the diagnosis, treatment, and management of non-Hodgkin’s lymphoma (NHL). This comprehensive guide bridges the gap between innovative research and clinical application, focusing on advancements in polymeric nanoparticles, lipid carriers, carbon nanotubes, and immunotherapy approaches. The book provides an in-depth analysis of current technologies and future directions in integrating nanocarriers into NHL management. Each chapter offers evidence-based insights and mechanisms of action, emphasizing the synergy between immunotherapy, precision medicine, and nanotechnology. This resource benefits its academic audience by equipping healthcare professionals with innovative strategies to improve treatment outcomes and inspiring researchers to explore novel therapeutic pathways. By fostering interdisciplinary collaboration among oncologists, pharmaceutical developers, and nanotechnology experts, the book ultimately guides future research to enhance patient care in the rapidly evolving field of non-Hodgkin’s lymphoma management.Offers in-depth analyses of various nanocarriers and therapeutic approaches, detailing their mechanisms of action and future potential in non-Hodgkin lymphoma managementEmphasizes cutting-edge, individualized therapeutic strategies, highlighting innovative treatments like CAR T-cell therapy and mRNA approaches that are crucial for personalized patient careIncludes practical chapters that address combination therapies and holistic patient care strategies, ensuring that healthcare professionals can effectively implement the latest advancements in their clinical practice

Role of Nanocarriers in Management of Non-Hodgkin Lymphoma is a pivotal resource that explores the transformative impact of nanotechnology on the diagnosis, treatment, and management of non-Hodgkin's lymphoma (NHL). This comprehensive guide bridges the gap between innovative research and clinical application, focusing on advancements in polymeric nanoparticles, lipid carriers, carbon nanotubes, and immunotherapy approaches. The book provides an in-depth analysis of current technologies and future directions in integrating nanocarriers into NHL management. Each chapter offers evidence-based insights and mechanisms of action, emphasizing the synergy between immunotherapy, precision medicine, and nanotechnology. This resource benefits its academic audience by equipping healthcare professionals with innovative strategies to improve treatment outcomes and inspiring researchers to explore novel therapeutic pathways. By fostering interdisciplinary collaboration among oncologists, pharmaceutical developers, and nanotechnology experts, the book ultimately guides future research to enhance patient care in the rapidly evolving field of non-Hodgkin's lymphoma management. - Offers in-depth analyses of various nanocarriers and therapeutic approaches, detailing their mechanisms of action and future potential in non-Hodgkin lymphoma management- Emphasizes cutting-edge, individualized therapeutic strategies, highlighting innovative treatments like CAR T-cell therapy and mRNA approaches that are crucial for personalized patient care- Includes practical chapters that address combination therapies and holistic patient care strategies, ensuring that healthcare professionals can effectively implement the latest advancements in their clinical practice

Nanocarrier-Based Immunotherapy: Emerging Frontiers in Cancer explores innovative nanotechnology approaches to enhance cancer immunotherapy. This comprehensive volume addresses the design, mechanisms, and clinical potential of nanocarriers such as polymeric nanoparticles, liposomes, dendrimers, exosomes, and inorganic nanomaterials in modulating immune responses against tumors. The book provides in-depth coverage of foundational principles, recent advancements, and translational strategies. In addition, it discusses how nanocarriers improve targeted delivery, overcome tumor immune evasion, and enable combination therapies.Chapters highlight cutting-edge topics like AI integration, safety profiles, and regulatory considerations, offering a multidisciplinary perspective. Designed for an academic audience, this resource facilitates understanding of nanomedicine’s role in cancer treatment. It equips researchers, clinicians, and students with scientific insights, novel strategies, and practical solutions to accelerate the development of next-generation immunotherapies.Bridges fundamental research and translational medicine-covering safety, regulatory issues, and scalability for clinical deployment.Highlights recent technological innovations and clinical applications-including AI integration, exosome engineering, and inorganic nanomaterialsProvides a comprehensive overview of nanocarrier systems

Two Sides of Nanovaccines and Nanomedicines in Cancer Treatments provides a balanced exploration of the dual roles of nanotechnologies in oncology. Structured in four parts, the book begins with foundational knowledge of nanovaccines and nanomedicines, detailing their applications in cancer care and highlighting their precision in targeting cancer cells while reducing systemic toxicity. Importantly, the book addresses potential drawbacks, discussing side effects and safety concerns associated with these innovations. The final section emphasizes ethical, regulatory, and safety challenges, underscoring the need for careful oversight as nanotechnologies advance.For the academic audience, this book serves as a vital resource, offering insights that equip researchers and healthcare professionals to make informed decisions regarding clinical applications. Its focus on both benefits and risks, alongside forward-looking perspectives, ensures that readers are well-prepared for future developments in the field of nanomedicine and cancer therapy.Provides an in-depth foundation on nanovaccines and nanomedicines, detailing their mechanisms, roles, and applications in cancer treatmentAddresses both the advantages and potential side effects of nanovaccines and nanomedicinesEmphasizes the ethical, safety, and regulatory aspects of nanotechnology in cancer therapy, offering valuable guidance for responsible usage and oversight in clinical settings

Two Sides of Nanovaccines and Nanomedicines in Cancer Treatments provides a balanced exploration of the dual roles of nanotechnologies in oncology. Structured in four parts, the book begins with foundational knowledge of nanovaccines and nanomedicines, detailing their applications in cancer care and highlighting their precision in targeting cancer cells while reducing systemic toxicity. Importantly, the book addresses potential drawbacks, discussing side effects and safety concerns associated with these innovations. The final section emphasizes ethical, regulatory, and safety challenges, underscoring the need for careful oversight as nanotechnologies advance.For the academic audience, this book serves as a vital resource, offering insights that equip researchers and healthcare professionals to make informed decisions regarding clinical applications. Its focus on both benefits and risks, alongside forward-looking perspectives, ensures that readers are well-prepared for future developments in the field of nanomedicine and cancer therapy. - Provides an in-depth foundation on nanovaccines and nanomedicines, detailing their mechanisms, roles, and applications in cancer treatment- Addresses both the advantages and potential side effects of nanovaccines and nanomedicines- Emphasizes the ethical, safety, and regulatory aspects of nanotechnology in cancer therapy, offering valuable guidance for responsible usage and oversight in clinical settings